Table 3.
Treatment | Intention to Treat (n = 33) | Study Completers (n = 26) | |||||||
---|---|---|---|---|---|---|---|---|---|
Mean Δ | SD | Fa | p | Mean Δ | SD | Fa | p | Cohen’s db | |
PSRS | |||||||||
TAU | 2.94 | 12.28 | 1.80 | 0.19 | 6.54 | 10.43 | 6.19 | *0.02 | 0.89 |
AE | − 1.31 | 6.83 | − 1.62 | 7.60 | |||||
SANS | |||||||||
TAU | − 0.76 | 5.33 | 0.54 | 0.47 | − 0.46 | 2.07 | 0.32 | 0.58 | 0.19 |
AE | − 1.00 | 5.74 | − 0.85 | 1.99 | |||||
SLOF | |||||||||
TAU | − 1.18 | 3.61 | 2.65 | 0.11 | − 1.38 | 4.11 | 1.57 | 0.22 | 0.69 |
AE | 1.00 | 3.16 | 1.23 | 3.49 |
*p < .05; TAU treat-as-usual, AE aerobic exercise, PSRS Provision of Social Relations Scale, SANS Scale for the Assessment of Negative Symptoms (Item 20); SLOF Specific Level of Functioning (informant version) – Interpersonal domain; Lower scores on the PSRS & SANS and higher scores on the SLOF indicate better social functioning; aControlling for the impact of sex, age, and changes in antipsychotic medication; bFor study completers